ReviewInternational journal of molecular sciences2017

Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation.

Girolamo Ranieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.